{"transactions":[{"id":338,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":323,"kind":"person","name":"Ashe Carol Gail","position":1,"cik":"0001761748","reported_name":"Ashe Carol Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-02T20:04:55.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":21750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders."}],"balance_after":21750,"derivative":{"exercise_price":2.7,"expiration_date":"2036-08-31","underlying":"Common Stock","underlying_shares":21750},"source":{"system":"sec-edgar","filing":"0001761748-26-000002","document":"wk-form4_1788379493.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761748/000176174826000002/wk-form4_1788379493.xml","form_type":"4"}},{"id":1140515,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":323,"kind":"person","name":"Ashe Carol Gail","position":1,"cik":"0001761748","reported_name":"Ashe Carol Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T16:08:00.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":7900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":7900,"derivative":{"exercise_price":5.84,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":7900},"source":{"system":"sec-edgar","filing":"0001601485-25-000090","document":"wk-form4_1747771672.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761748/000160148525000090/wk-form4_1747771672.xml","form_type":"4"}},{"id":1352794,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":323,"kind":"person","name":"Ashe Carol Gail","position":1,"cik":"0001761748","reported_name":"Ashe Carol Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-25T07:36:14.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":5.12,"expiration_date":"2034-11-21","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001601485-24-000097","document":"wk-form4_1732538168.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761748/000160148524000097/wk-form4_1732538168.xml","form_type":"4"}},{"id":1655906,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":323,"kind":"person","name":"Ashe Carol Gail","position":1,"cik":"0001761748","reported_name":"Ashe Carol Gail","relationship":{"director":true}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-02-07T21:44:00.000Z","date":"2024-02-05","kind":"grant","planned":false,"acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows:  50% on February 5, 2025; 25% on February 5, 2026; and 25% on February 5, 2027."}],"balance_after":3333,"derivative":{"exercise_price":2,"expiration_date":"2034-02-05","underlying":"Common Shares","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0000912282-24-000120","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000091228224000120/form4.xml","form_type":"4"}},{"id":1697993,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":323,"kind":"person","name":"Ashe Carol Gail","position":1,"cik":"0001761748","reported_name":"Ashe Carol Gail","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-12-29T17:05:36.000Z","date":"2023-12-28","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":8.26,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001140361-23-060236","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1761748/000114036123060236/form4.xml","form_type":"4"}},{"id":2049015,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":323,"kind":"person","name":"Ashe Carol Gail","position":1,"cik":"0001761748","reported_name":"Ashe Carol Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-01-24T00:51:52.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent (50%) of the options vest on January 19, 2024, twenty-five percent (25%) vest on January 19, 2025, and twenty-five percent (25%) vest on January 19, 2026."}],"balance_after":100000,"derivative":{"exercise_price":0.66,"expiration_date":"2033-11-19","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001567619-23-001155","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761923001155/doc1.xml","form_type":"4"}},{"id":2431440,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":323,"kind":"person","name":"Ashe Carol Gail","position":1,"cik":"0001761748","reported_name":"Ashe Carol Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-01-20T23:04:15.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on January 18, 2022, and vest as follows:  50% vest on January 18, 2023; 25% vest on January 18, 2024; and 25% vest on January 18, 2025."}],"balance_after":50000,"derivative":{"exercise_price":1.34,"expiration_date":"2032-01-17","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-22-001381","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761922001381/doc1.xml","form_type":"4"}},{"id":2917335,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":323,"kind":"person","name":"Ashe Carol Gail","position":1,"cik":"0001761748","reported_name":"Ashe Carol Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-01-06T21:41:27.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on January 4, 2021, and vest as follows:  50% vest on January 4, 2022; 25% vest on January 4, 2023; and 25% vest on January 4, 2024."}],"balance_after":50000,"derivative":{"exercise_price":4.37,"expiration_date":"2031-01-04","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-21-000571","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761921000571/doc1.xml","form_type":"4"}},{"id":3212075,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":323,"kind":"person","name":"Ashe Carol Gail","position":1,"cik":"0001761748","reported_name":"Ashe Carol Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Option Grant","published_at":"2020-03-14T00:55:00.000Z","date":"2020-03-11","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":7.08,"exercise_date":"2021-03-11","expiration_date":"2030-03-10","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-20-006350","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761920006350/doc1.xml","form_type":"4"}},{"id":3295519,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":323,"kind":"person","name":"Ashe Carol Gail","position":1,"cik":"0001761748","reported_name":"Ashe Carol Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Option Grant","published_at":"2020-02-04T02:32:52.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent (50%) of the options vest on 1/31/2021.  The remaining 50% vest as follows:  one-half on 1/31/2022 and one-half on 1/31/2023."}],"balance_after":65000,"derivative":{"exercise_price":6.91,"expiration_date":"2030-01-30","underlying":"Common Shares","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001567619-20-001972","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761920001972/doc1.xml","form_type":"4"}},{"id":3710951,"issuer":{"id":33387,"kind":"organization","name":"Aptose Biosciences Inc.","symbol":"APTO"},"owners":[{"id":323,"kind":"person","name":"Ashe Carol Gail","position":1,"cik":"0001761748","reported_name":"Ashe Carol Gail","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2019-01-04T01:03:52.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest fully on the first anniversary of the grant."}],"balance_after":40000,"derivative":{"exercise_price":1.91,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001567619-19-000419","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882361/000156761919000419/doc1.xml","form_type":"4"}}]}